Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
China
· Delayed Price · Currency is CNY 5.28
0.00 (0.00%)
At close: Mar 10, 2026
SHE:000597 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,535 | 7,531 | 7,646 | 9,051 | 8,384 | 6,848 | Upgrade
|
| Market Cap Growth | -1.26% | -1.49% | -15.52% | 7.95% | 22.43% | 1.46% | Upgrade
|
| Enterprise Value | 5,530 | 4,778 | 5,667 | 7,484 | 8,815 | 8,080 | Upgrade
|
| Last Close Price | 5.28 | 5.17 | 5.13 | 5.95 | 5.85 | 4.76 | Upgrade
|
| PE Ratio | 19.91 | 18.38 | 21.33 | 25.84 | 84.66 | 558.71 | Upgrade
|
| Forward PE | - | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 | Upgrade
|
| PS Ratio | 1.10 | 1.00 | 0.93 | 1.03 | 1.03 | 0.93 | Upgrade
|
| PB Ratio | 1.35 | 1.35 | 1.48 | 1.92 | 1.95 | 1.66 | Upgrade
|
| P/TBV Ratio | 1.65 | 1.68 | 1.79 | 2.37 | 2.42 | 2.09 | Upgrade
|
| P/FCF Ratio | 12.07 | 12.57 | 21.76 | 10.47 | 13.38 | 40.16 | Upgrade
|
| P/OCF Ratio | 10.62 | 9.93 | 13.03 | 8.16 | 11.23 | 12.00 | Upgrade
|
| EV/Sales Ratio | 0.81 | 0.64 | 0.69 | 0.85 | 1.08 | 1.09 | Upgrade
|
| EV/EBITDA Ratio | 5.57 | 4.69 | 6.22 | 9.92 | 12.20 | 11.64 | Upgrade
|
| EV/EBIT Ratio | 12.87 | 10.04 | 15.48 | 34.09 | 41.85 | 37.84 | Upgrade
|
| EV/FCF Ratio | 8.86 | 7.97 | 16.13 | 8.66 | 14.07 | 47.38 | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.29 | 0.42 | 0.47 | 0.58 | 0.63 | Upgrade
|
| Debt / EBITDA Ratio | 1.87 | 1.53 | 2.32 | 2.81 | 3.27 | 3.74 | Upgrade
|
| Debt / FCF Ratio | 2.98 | 2.66 | 6.21 | 2.54 | 3.97 | 15.25 | Upgrade
|
| Net Debt / Equity Ratio | -0.40 | -0.52 | -0.67 | -0.35 | -0.01 | 0.27 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.31 | -2.82 | -3.80 | -2.18 | -0.09 | 1.61 | Upgrade
|
| Net Debt / FCF Ratio | -3.58 | -4.80 | -9.87 | -1.91 | -0.10 | 6.56 | Upgrade
|
| Asset Turnover | 0.49 | 0.51 | 0.57 | 0.65 | 0.64 | 0.60 | Upgrade
|
| Inventory Turnover | 3.55 | 3.53 | 3.97 | 4.50 | 4.04 | 3.62 | Upgrade
|
| Quick Ratio | 0.95 | 0.87 | 0.86 | 0.78 | 0.65 | 0.57 | Upgrade
|
| Current Ratio | 1.12 | 1.05 | 1.02 | 0.94 | 0.83 | 0.76 | Upgrade
|
| Return on Equity (ROE) | 6.65% | 7.89% | 7.62% | 7.93% | 2.27% | 0.27% | Upgrade
|
| Return on Assets (ROA) | 1.91% | 2.00% | 1.57% | 1.02% | 1.04% | 1.08% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.26% | 15.47% | 11.86% | 4.09% | 3.53% | 0.47% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.90% | 7.70% | 6.40% | 4.10% | 4.20% | 4.40% | Upgrade
|
| Earnings Yield | 4.97% | 5.44% | 4.69% | 3.87% | 1.18% | 0.18% | Upgrade
|
| FCF Yield | 8.29% | 7.96% | 4.59% | 9.55% | 7.47% | 2.49% | Upgrade
|
| Dividend Yield | 1.89% | 1.93% | 1.95% | 1.68% | 0.24% | 0.17% | Upgrade
|
| Payout Ratio | 58.19% | 50.30% | 61.31% | 31.25% | 167.14% | 1019.51% | Upgrade
|
| Buyback Yield / Dilution | 1.21% | 1.43% | -2.34% | 0.97% | -15.42% | 8.41% | Upgrade
|
| Total Shareholder Return | 3.13% | 3.37% | -0.40% | 2.65% | -15.18% | 8.58% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.